Regulatory & Compliance
The Regulation of CANNABIS, HEMP/“HEMP”, MARIJUANA/HASHISH, THC, CBD AND THEIR DERIVATIVES. Legalisation in the USA
·
The recent news of the “legalisation of “hemp” (industrial hemp) in the United States of America (hereinafter USA) has been disseminated through social media and the press with some analysis and, above all, considerable confusion regarding its legal substance and expectations of the general legalisation of marijuana consumption.
The confusion is greater when, in parallel, there are reports of the legalisation of medicinal and also recreational uses of cannabis in various countries around the world (the Netherlands, certain USA states such as California, Nevada…, Canada, Peru, Uruguay, Colombia, Mexico, some political debate in Spain, etc…).
The purpose of this note is to place the Federal “legalisation” of hemp within the USA regulatory framework in its proper context, and to distinguish it from the plant of the same cannabis family known as “marijuana”. Not to delve into botanical, chemical, agricultural or industrial and commercial knowledge of products derived from plants of the various cannabis subspecies and their hybrids, but rather to understand the legal status of the realities involved, which does not always correspond to those realities stricto sensu.
The history of a blanket prohibition of cannabis
The regulation of industrial hemp planting is an example of a matter whose regulatory treatment by regulators consisted of disregarding the study of the different realities, advantages and disadvantages surrounding cannabis, without therefore examining its various subspecies and its many beneficial uses in depth, and simply imposing an outright, total prohibition on any cultivation and commercial trade, save for exceptions for medical uses and other very specific circumstances. In the USA, the de facto prohibition arose from an industrial battle and a tax issue. It was industrial interests and taxes that once again determined the course of a history.
The “Marihuana Tax Act” of 1937 marked the beginning of the end of an industry that had until then been prosperous, and was motivated by the idea of reducing the scale of cannabis agriculture and industry, owing, on the one hand, to “police concern over vice (the 1930s)”; on another, to imposing the tax on prescriptions for therapeutic uses on doctors and pharmacists; and on another, to the interests of paper companies and the new nylon industry, with which industrial hemp competed. In practice, therapeutic use almost disappeared and, “as a side effect”, so did industrial uses.
Later, the prohibition became more firmly established when marijuana was included in the 1961 United Nations Convention on Narcotic Drugs and in subsequent conventions on narcotics trafficking, as well as in the national laws of many countries.
The Marihuana Tax Act was repealed in the late 1960s and cannabis (without distinction between subspecies) was included in the Controlled Substances Act of 1970 (Schedule I, and therefore among the most dangerous substances).
The practical results of this total prohibition have proved, and not only in the USA, to run counter to its objectives and to trigger serious problems arising from high consumption based on the illegal trafficking of marijuana or other products from different parts of the plant, such as “hashish” or “kif”. Figures estimated by police and prosecution sources worldwide indicate that up to 4% of the entire adult population of the world regularly consumes the narcotic, and that too many young people also consume it. If we move beyond judicial data and into studies and surveys, the figure is very significant. In the European Union, according to the 2018 report of the European Monitoring Centre for Drugs and Drug Addiction[1], 14.1% of the population aged 15–34 report having consumed cannabis (marijuana or hashish) at some point in the last year; and 26.3% of all Europeans have done so during their lifetime. Approximately 1% of adults consume it almost daily, and some 150,000 people are receiving treatment. Consumption of narcotic cannabis is five times that of drugs such as cocaine and others.
Cultivation and, above all, illegal trafficking (criminalised under our Criminal Code and the criminal laws of most countries) supply that population with the product, free of taxes and consumption controls, and connected to multiple offences and minor offences that clog the courts. It may be said to be one of the industries in the underground economy of greatest concern for public safety, owing to its effects on health and its power to corrupt and induce numerous offences against persons and property. Interestingly, according to the aforementioned report of the European Monitoring Centre, Spain holds the absolute and unsurpassed record for seizures of cannabis in all its forms.
However, the study of illegal trafficking and its consequences is not the subject of this note.
Industrial hemp, which has been reclassified at federal level in the USA, is not “marijuana”
In the USA, at federal level, an Act containing cross-cutting measures for the improvement of agriculture is passed every five years, and the “Agricultural Improvement Act 2018 has just been enacted, in late 2018, introducing significant legislative amendments such as the distinction between cannabis subspecies and, ultimately, the “legalisation” of industrial hemp.
On the one hand, the “Agricultural Marketing Act” of 1946 is amended by introducing a legal framework for \»hemp\» or industrial hemp, which must be controlled through State (or Indian Territory) plans and licences for farmers, based on crop monitoring and control, as well as the crop insurance scheme [2]
On the other hand, “industrial hemp” is removed from the feared Controlled Substances Act of 1970, in which “marijuana” remains[3]
It may generally be stated that the varieties of cannabis plants called “industrial hemp” or ““hemp”” are those with a very low content of the psychotropic substance THC or tetrahydrocannabinol (less than 0.3% under the Act recently passed in the USA in 2018 and less than 0.2% in the European Union); they therefore pose little risk to health and, conversely, are highly useful for industrial, food, cosmetic and other purposes. Indeed, for example, the seeds are an extraordinarily nutritious food containing no THC.
In short, these varieties of hemp henceforth become an agricultural product controlled by the Department of Agriculture and not by the Drug Enforcement Administration (the well-known DEA). The USA thus completes a pilot programme of cultivation and consumption (industrial) trials begun four years ago, which has proved successful.
Some say that the measure is partly driven by the fall in USA exports of cereals, rapeseed, maize and soya and the consequent reduction in production resulting from the current Administration's tariff and trade protectionism, offering producers a crop of value in multiple applications that is very widespread in China, which exports raw materials and numerous products made from the aforementioned derivatives.
The uses of “hemp”: from building materials to food and cosmetics. CBD.
This reopens, in the United States and at federal level, a truly important agricultural and processing industry owing to the multiple uses of “hemp” plants, particularly their stalks and seeds, to replace plastics, to produce cellulose while avoiding the felling of forests, since these are annual plants); to make furniture and joinery in general by forming composites of better quality than wood; it can also serve (particularly the seeds) as a complete and excellent protein-rich food; or its vegetable oils, clothing, footwear, paints, motor vehicle parts and similar items, cosmetics, packaging, biofuels, building materials and, furthermore, it is naturally biodegradable. The global “hemp” market is expected to reach a value of more than ten billion USA dollars in just over four years. For farmers, returns from “hemp” will improve by some US$300 per hectare compared with other current crops.
Beyond “hemp” or industrial hemp, now fully normalised in the USA, undoubtedly one of the leading cannabis products is CBD or cannabidiol (C21H30 O2), a non-psychoactive substance (unlike another of its substances, THC) used in therapies for pain, anxiety and schizophrenia, being tested for heart disease and also as an inhibitor of the growth of certain breast and other tumours, as well as a relaxant. CBD is present in proportions suitable for ordinary extraction in certain plant varieties (to a lesser extent in industrial varieties). THC, the compound with a psychotropic effect, is present in appreciable proportions in non-industrial varieties; indeed, the marijuana or hashish that crosses the Strait of Gibraltar almost daily contains THC in proportions of 7 to 15% (which may reach 29% in other varieties), obtained mainly from the resins.
Farmers growing cannabis could multiply the returns from current irrigated crops by 12 to 14 when the harvest is intended for CBD extraction.
It is true that the boundaries between the different varieties and the means of controlling the different uses are not obvious, but technically inspection and control are entirely feasible, as demonstrated by the American Act. Hence cultivation for medical and recreational uses is growing worldwide, with considerable interest from the financial sector.
SPAIN. The regulatory position of cannabis, hemp and marijuana/hashish.
In Spain, there are currently some 20,000 hectares that could be accommodating this crop under administrative licences for different purposes, although there are no public data on whether or not all of them are under cultivation.
However, there are highly confused opinions about its legal framework, judging by recent legislative proposals. Parliamentary statements in different directions in the national and regional chambers reveal a significant level of ignorance of this subject and confusion; even within the party currently in the national Government and those governing several Autonomous Communities. Initiatives are being put forward for and against the medicinal use of certain cannabinoids and even so-called “recreational use”, while, simultaneously, the Minister for Health (with responsibility for this matter) declares that this issue is not on the Spanish Government's agenda.
We could distinguish the legal regime applicable to cannabis plants according to whether their THC content is above or below 0.2% (that is, whether or not they are considered a \»narcotic\».
- a/ The basic Spanish national legislation concerning non-industrial cannabis (THC content > 0.2%) is as follows:
Law 17/1967, of 8 April, updating the rules in force on narcotic drugs and adapting them to the provisions of the 1961 United Nations Convention. It subjects their cultivation, processing, use and handling to specific administrative authorisation (Articles five, seven and eight), but excludes hemp containing no psychotropic substances.
Furthermore, Article 368 of the Criminal Code provides:
“Those who carry out acts of cultivation, production or trafficking, or otherwise promote, encourage or facilitate the illegal consumption of toxic drugs, narcotic drugs or psychotropic substances, or possess them for those purposes, shall be punished by imprisonment for three to six years and a fine of between one and three times the value of the drugs forming the subject matter of the offence where the substances or products cause serious harm to health, and by imprisonment for one to three years and a fine of between one and twice that value in all other cases.
Notwithstanding the provisions of the preceding paragraph, the courts may impose a penalty one degree lower than those indicated, having regard to the minor nature of the act and the personal circumstances of the offender. This power may not be exercised where any of the circumstances referred to in Articles 369 bis and 370 apply.”
Articles 369 et seq. of the Criminal Code (CP) govern the relevant circumstances and the increases and reductions in penalties applicable according to them.
Furthermore, pursuant to Law 25/1990, of 20 December, on medicinal products, Order SCO/190/2004, of 28 January, which supplements it, declares the sale of the cannabis plant (hemp is also expressly mentioned), including the entire plant and any preparation thereof, to be prohibited or restricted. The uses and marketing of the plants listed in this Order are restricted to the manufacture of proprietary medicinal products, magistral formulae, officinal preparations, homeopathic stocks and research, excluding direct use or preparations.
For its part, Organic Law 4/2015, of 30 March, on the protection of public security defines the following as a serious administrative offence in Article 36:
- The unlawful consumption or possession of toxic drugs, narcotic drugs or psychotropic substances, even if not intended for trafficking, in public places, thoroughfares, establishments or collective transport, as well as the abandonment of instruments or other items used for that purpose in those places.
The commission of this offence is punishable by a fine of 601 to 30,000 euros according to scales of seriousness.
- b/ As regards industrial hemp or “hemp” (varieties containing less than 0.2% THC), the basic legislation applicable in Spain is:
Law 17/1967, of 8 April, updating the rules in force on narcotic drugs and adapting them to the provisions of the 1961 United Nations Convention:
“Article nine.: The preceding provisions shall not apply to the cultivation of the «cannabis» plant intended for industrial purposes, provided that it contains no active narcotic ingredient.”
Council Regulation (EC) No 1673/2000 of 27 July 2000 governs the production of hemp fibres and seeds, providing for Common Agricultural Policy (CAP) aid.
Royal Decree 940/2001, of 3 August, laying down rules governing processing aid in the flax and hemp sector for fibre production.
Royal Decree 1729/1999, of 12 November, laying down the rules for applying for and granting aid for textile flax and hemp.
In short, it seems clear that the cultivation and production of subspecies of the narcotic cannabis plant, as well as the production and marketing or trafficking of its derivatives known as marijuana, “hashish”, “grifa”, or colloquially “costo\» or \»chocolate”), are clearly criminalised, except in those cases in which specific administrative authorisation is obtained from the Narcotics Control Service; whereas the consumption of these derivatives is only considered an administrative offence if it takes place on public premises. As regards their use for other therapeutic or medicinal purposes, the legal framework governing the Law on medicinal products and the use of narcotic substances must be observed.
By contrast, cultivation and processing for the use of “industrial hemp” (fibre, cosmetics, food) are not technically subject to administrative authorisation. However, owing to its inclusion (perhaps erroneous) in the aforementioned Order, its direct sale as a plant or preparation is technically prohibited (but not covered by the Criminal Code where it does not qualify as a \»narcotic\»). Finally, its use in various derived products is not subject to any restrictions other than those applicable to each type of product.
The development of European and Spanish regulations
It is foreseeable that Spain and the vast majority of European Union countries, as well as EU regulators, will adjust their regulations in line with the American Act of 2018, for example by aligning the rules on maximum THC content with those of the USA and Canada (0.2% as against 0.3%) and relaxing the excessively restrictive and unfounded regulations currently governing the cultivation, handling and trade of industrial hemp, which in practice render it uncompetitive with those countries or with China. This has been requested, for example, in the Cologne Declaration of 07/07/17 of the European Industrial Hemp Association (EIHA)[4]
It is also possible that the deficient regulatory framework currently governing other uses of substances other than THC (CBD and others), particularly therapeutic, nutritional, cosmetic and similar uses, will be updated, and attention will even need to be paid to the effects and results being obtained in more than 30 USA states and other countries following decriminalisation and broad regulation of therapeutic use, as well as certain recreational consumption uses, controlling THC content and thereby reducing much of the harm currently caused by the illegal consumption of its narcotic form, and a substantial proportion of the effects of illegal trafficking.
LOYRA, Abogados. (Regulated Sectors Practice)
[1]See http://www.emcdda.europa.eu/system/files/publications/8585/20181816_TDAT18001ESN_PDF.pdf
P.40 et seq.
<a href=" rel="noopener noreferrer" target="_blank">[2] See the Agricultural Improvement Act of 2018 at https://www.congress.gov/bill/115th-congress/house-bill/2/text?r=3
in particular Section 10113, which concerns the regime governing the cultivation of ““hemp””
[3] See the same Act cited above, this time in Section 12619
[4]